Exploring the Role of Alcohol Metabolizing Genotypes in a 12-Week Clinical Trial of Naltrexone for Alcohol Use Disorder

Background: The efficacy of naltrexone in the treatment of alcohol use disorder (AUD) has been associated with a set of variables not directly related with the expression of opioid receptors. All the variables have been found to be highly associated with AUD itself or more severe clinical levels of...

Descripción completa

Detalles Bibliográficos
Autores principales: Castaldelli-Maia, João M., Malbergier, André, de Oliveira, Adriana B. P., Amaral, Ricardo A., Negrão, André B., Gonçalves, Priscila D., Ventriglio, Antonio, de Berardis, Domenico, de Antonio, Juliana, Firigato, Isabela, Gattás, Gilka J. F., de Toledo Gonçalves, Fernanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533258/
https://www.ncbi.nlm.nih.gov/pubmed/34680127
http://dx.doi.org/10.3390/biom11101495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533258/
https://www.ncbi.nlm.nih.gov/pubmed/34680127
http://dx.doi.org/10.3390/biom11101495

Ejemplares similares